About: http://data.cimple.eu/news-article/658665aa0e7840eb2fc54b60aa5c022eeab433691510ae66b181db13

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/658665aa0e7840eb2fc54b60aa5c022eeab433691510ae66b181db13 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	With the EU's vaccination rollout picking up, the European Commission said Thursday it would back a new generation of improved coronavirus treatments, especially for people suffering "long Covid". "It's really crucial that, alongside vaccines, we also step up our work on therapeutics," EU health commissioner Stella Kyriakides told a media conference. The commission's strategy aims to build a bigger treatment portfolio going beyond the one medicine that has so far proved effective: the antiviral drug Remdesivir. "We will aim to, by October, develop and authorise three new effective Covid-19 therapeutics ... and another two potentially by the end of the year," Kyriakides said. The strategy also looks to boost research and clinical studies and speed up authorisation of medicines in EU member states. The commission said it will throw five million euros ($6 million) at clinical trial safety assessments, another five million euros to map treatments being developed and what supply chains they would need, and provide 40 million euros to support the manufacture of remedies. Improvements in this area could greatly help the 10 to 15 percent of people who have survived Covid-19 but who complain of "long Covid", with symptoms of fatigue, impaired concentration, body pain and breathing and respiratory problems that linger after the infection has gone. The reasons for such ailments are not clearly understood at this stage, as so much with the coronavirus and its health effects. But Kyriakides emphasised that, even with vaccinations, Covid is likely to become endemic and "we will have to deal with" it, hopefully by managing and minimising it as we do with the flu. jug/rmb/dc/pvh
schema:headline	EU working towards 'long Covid' treatments
schema:mentions	Jug Endemism Stella Kowalski Traditional Chinese medicine European Commission Renminbi Fatigue Clinical trial Antiviral drug Remdesivir Pain Influenza European Union Coronavirus disease Vaccine Coronavirus disease 2019 PVH (company)
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-05-06 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	86 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software